Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | AOC2 | O75106 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL171860 | 0.83 | HPGD (0.59) | LMNAPOLBMEN1KMT2AHPGD | |
| SCHEMBL10569182 | 0.83 | CA2 (0.56) | LMNACA2POLBHTTHDAC4 | |
| SCHEMBL1972574 | 0.83 | LMNA (0.68) | LMNACA2POLBHTTHDAC4 | |
| SCHEMBL4475117 | 0.83 | PLK1 (0.59) | LMNAPOLBHTTHDAC4TDP1 | |
| SCHEMBL1632446 | 0.81 | LMNA (0.51) | LMNAPOLBHTTHDAC4TDP1 | |
| SCHEMBL9199667 | 0.81 | LMNA (0.47) | LMNAPOLBHTTHDAC4TDP1 | |
| SCHEMBL14394201 | 0.81 | GLS (0.50) | LMNAPOLBHTTHDAC4TDP1 | |
| SCHEMBL8135278 | 0.81 | KLKB1 (0.52) | LMNAPOLBHTTHDAC4TDP1 | |
| SCHEMBL3324450 | 0.81 | KMT2A (0.59) | LMNAHTTMEN1KMT2A | |
| SCHEMBL1137228 | 0.81 | GAA (0.63) | LMNAHTTTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 661 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230076173-A1 | ANTIMICROBIAL MATRIX AND USES THEREOF FOR ELIMINATING MICROORGANISMS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-03-09 | — | — | US | claimed |
| EP-4100070-A1 | ANTIMICROBIAL MATRIX AND USES THEREOF FOR ELIMINATING MICROORGANISMS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2022-12-14 | — | — | EP | claimed |
| WO-2021156877-A1 | ANTIMICROBIAL MATRIX AND USES THEREOF FOR ELIMINATING MICROORGANISMS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2021-08-12 | — | — | WO | claimed |
| US-20050261475-A1 | Solid-phase capture-release-tag methods for phosphoproteomic analyses | HARVARD MEDICAL SCHOOL (US) | 2005-11-24 | — | — | US | claimed |
| EP-0418617-B1 | Method for preparing human osteocalcin | MITSUBISHI PETROCHEMICAL CO (JP) | 1994-11-09 | — | — | EP | claimed |
| US-5164483-A | Bone disorder diagnosis | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1992-11-17 | — | — | US | claimed |
| EP-0418617-A1 | Method for preparing human osteocalcin | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-03-27 | — | — | EP | claimed |
| US-4293455-A | N.sup.α -Desacetylthymosinα1 and process | ROCKEFELLER UNIVERSITY (US) | 1981-10-06 | — | — | US | claimed |
| JP-1296996-A | — | — | None | — | — | JP | disclosed |
| JP-4149197-A | — | — | None | — | — | JP | disclosed |
| JP-63190900-A | — | — | None | — | — | JP | disclosed |
| EP-4626955-A2 | POLY(ETHYLENE GLYCOL)-POLYOXAZOLINE (PEOZ) COPOLYMERS FOR SOLUBILIZING DRUGS, DYES, AND BIOPHARMACEUTICALS | Becton, Dickinson and Company (US) | 2025-10-08 | — | — | EP | disclosed |
| CN-120051508-A | Polyethylene glycol-Polyoxazoline (PEOZ) copolymers for dissolving drugs, dyes and biopharmaceuticals | 贝克顿·迪金森公司 | 2025-05-27 | — | — | CN | disclosed |
| WO-2024143052-A1 | PEPTIDE SYNTHESIS METHOD | 学校法人神戸学院 | 2024-07-04 | — | — | WO | disclosed |
| US-4824937-A | Synthetic natriuretic peptides | 501 Advanced Peptide Development, Ltd. (GB) | 1989-04-25 | — | — | US | disclosed |
| WO-1989000166-A2 | GROWTH HORMONE RELATED PEPTIDE | PEPTIDE TECHNOLOGY LTD (AU) | 1989-01-12 | — | — | WO | disclosed |
| US-4769445-A | Process for the solid phase synthesis of peptides which contain sulfated tyrosine | PENNWALT CORPORATION (US) | 1988-09-06 | — | — | US | disclosed |
| JP-S63190900-A | NOVEL PEPTIDE | KAJI AKIRA | 1988-08-08 | — | — | JP | disclosed |
| EP-0246795-A2 | Synthetic natriuretic peptides | ADVANCED PEPTIDE DEVELOPMENT LIMITED (GB) | 1987-11-25 | — | — | EP | disclosed |
| EP-0161468-A2 | Process for the solid phase synthesis of peptides which contain sulfated tyrosine | PENNWALT CORPORATION (US) | 1985-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261475-A1 | Solid-phase capture-release-tag methods for phosphoproteomic analyses | PTMS, CHAMP1, ACP1 | LMNA 2867/4885CA1 2212/4885CA2 2481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.